RetinAI Discovery Transformative AI & data management platform for healthcare decision-making

What is RetinAI Discovery?

RetinAI Discovery stands at the forefront of healthcare innovation, offering a comprehensive data management and analysis platform specifically designed for ophthalmology. The platform seamlessly integrates multiple data formats, from DICOM-compliant imaging to proprietary formats, while providing advanced AI-powered analysis capabilities for disease progression and treatment outcomes.

The platform features CE-marked AI models for OCT analysis, layer and fluid segmentation, and supports various ophthalmological conditions including AMD, DR, DME, CME, and GA. With its cloud-based infrastructure, the system enables secure global collaboration, real-time data monitoring, and automated biomarker analysis, serving both clinical practice and research environments.

Features

AI Analysis: CE-marked biomarkers and automatic layer and fluid segmentation
Data Integration: Support for multiple imaging formats and data types
Secure Collaboration: GDPR, HIPAA & PIPEDA compliant platform
Real-time Monitoring: Instant access to study progress and patient data
Automated Biomarker Analysis: 30+ CE marked and Research Use Only biomarkers
Natural Language Search: Advanced patient cohort identification
Multi-center Management: Centralized data collection and analysis
Disease-Specific Focus: Specialized tools for AMD, DR, DME, CME and GA

Use Cases

Clinical trial data management
Patient monitoring and disease progression tracking
Multi-center research collaboration
Real-world evidence generation
Ophthalmology imaging analysis
Tele-ophthalmology services
Drug development research
Clinical decision support

FAQs

What types of medical imaging formats does RetinAI Discovery support?

RetinAI Discovery supports DICOM-compliant formats, OCTs, Fundus images, PDFs, JPEG, PNG & TIFF files.
What security compliance standards does the platform meet?

The platform is compliant with EU GDPR, HIPAA & Canadian PIPEDA rules for data privacy and security.
What eye conditions can the AI models analyze?

The platform supports assessment of AMD, DR, DME, CME and GA (Geographic Atrophy) conditions.